S. no | Disorder and Gene | Transcript no. | Number of Variants | Variant description: cDNA position Protein change | ACMG criteria | No of individuals |
---|---|---|---|---|---|---|
1 | Deafness, AR 4, with enlarged vestibular aqueduct, SLC26A4 | ENST00000265715 | 4 | c.1001G > T, p.Gly334Val | PS3 + PM2 + PP2 + PP3 + PP4 + PP5 | 2 |
c.1226G > C, p.Arg409Proa | PM2 + PM5 + PP2 + PP3 + PP5 | 1 | ||||
c.1468A > C, p.Ile490Leua | PS1 + PM1 + PP2 + PP3 + PP5 | 1 | ||||
c.1003 T > C, p.Phe335Leu | PS1 + PP2 + PP3 + PP5 | 1 | ||||
2 | Deafness, AR,1A, GJB2 | ENST00000382844 | 2 | c.231G > A, p.Trp77Tera | PVS1 + PS3 + PM1 + PM4 + PP2 + PP3 | 2 |
c.71G > A, p.Trp24Tera | PVS1 + PS3 + PM1 + PM4 + PP2 + PP3 | 1 | ||||
3 | Deafness, AR, 8, TMPRSS3 | ENST00000291532 | 2 | c.413C > A, p.Ala138Glu | PM1 + PM2 + PP2 + PP3 | 1 |
c.323-6G > Aa | PS3 + PS4 + PM2 + PP3 | 2 | ||||
4 | Deafness AR,7, TMC1 | ENST00000297784 | 1 | c.1165C > T, p.Arg389Ter | PVS1 + PS3 + PM2 + PM4 + PP3 | 1 |
5 | Cystic fibrosis, CFTR | ENST00000003084 | 9 | c.223C > T, p.Arg75Ter | PVS1 + PS3 + PM2 + PM4 + PP2 + PP3 | 1 |
c.1646G > A, p.Ser549Asna | PS3 + PM1 + PM2 + PM5 + PP2 + PP3 + PP5 | 1 | ||||
c.595C > T, p.His199Tyr | PS3 + PM1 + PM2 + PM5 + PP2 + PP3 + PP5 | 1 | ||||
c.3209G > A, p.Arg1070Gln | PS3 + PM1 + PM5 + PP2 + PP3 + PP5 | 1 | ||||
p.Phe508del | PS3 + PM1 + PM4 + PP2 + PP3 | 1 | ||||
c.4096A > T, p.Ile1366Phe | PM1 + PM2 + PP2 + PP3 | 1 | ||||
c.1472G > T, p.Cys491Phe | PM1 + PM2 + PP2 + PP3 | 1 | ||||
c.4009 T > G, p.Phe1337Val | PM1 + PM2 + PP2 + PP3 | 1 | ||||
c.1859A > T, p.His620Leu | PM1 + PM2 + PM5 + PP2 + PP3 | 1 | ||||
6 | Glycogen storage disease II, GAA | ENST00000302262 | 1 | c.1933G > A, p.Asp645Asn | PS4 + PM1 + PM2 + PM5 + PP2 + PP3 + PP5 | 3 |